West Nile Virus Antibody Product Receives Conditional License
The USDA’s Animal Plant Health Inspection Service has issued a conditional license to Novartis Animal Vaccines, Inc., for the manufacture and distribution of West Nile Virus Antibody, Equine Origin, for treatment of disease caused by West Nile virus (WNV).
Typically, antibody products are very specific and mimic the activity of naturally occurring molecules used by the body’s immune
- Topics: Article
The USDA’s Animal Plant Health Inspection Service has issued a conditional license to Novartis Animal Vaccines, Inc., for the manufacture and distribution of West Nile Virus Antibody, Equine Origin, for treatment of disease caused by West Nile virus (WNV).
Typically, antibody products are very specific and mimic the activity of naturally occurring molecules used by the body’s immune system to combat disease
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with
